Journalartikel

Jahr der Veröffentlichung: 2010

Seiten: 5254-5259

Zeitschrift: Investigative Ophthalmology & Visual Science

Bandnummer: 51

Heftnummer: 10

ISSN: 0146-0404

DOI Link: https://doi.org/10.1167/iovs.09-5139

Verlag: Association for Research in Vision and Ophthalmology

Abstract: 

PURPOSE. Retinal blood vessel diameter and arteriovenous ratio (AVR) are commonly used diagnostic parameters. Because vascular walls are typically not visible in funduscopy, clinical AVR estimation is based on the lumen rather than the entire vessel diameter. Here the authors used a transgenic mouse model to quantify AVR in vivo based on total vessel dimensions (wall and lumen).

METHODS. Confocal scanning laser ophthalmoscopy (cSLO) and indocyanine green angiography of the retinal vasculature were performed in wild-type and transgenic mice expressing green fluorescent protein (GFP) under the transcriptional control of the smooth muscle type alpha-actin (alpha SMA) promoter. Spectral-domain-OCT and ERG were performed to control for integrity of retinal structure and function in vivo and histology to demonstrate the location of GFP expression.

RESULTS. Native cSLO imaging and angiography yielded only inner vessel diameters similar to those observed through clinical funduscopy. In alpha SMA-GFP mice, autofluorescence imaging of the GFP-marked vascular walls also allowed the determination of outer vessel diameters. The mean AVR based on either inner diameter (AVR(id) = 0.72 +/- 0.08) or outer diameter (AVR(od) = 0.97 +/- 0.09) measurements were significantly different (P < 0.01).

CONCLUSIONS. Transgenic alpha SMA-GFP expression in murine vessel wall components allowed quantification of retinal vessel outer diameters in vivo. Although arterioles and venules differ in lumen and vessel wall width, they share a common outer diameter, leading to an AVR(od) close to unity. Because vessel walls are primary targets in common hypertensive and metabolic diseases, alpha SMA-GFP transgenic mice may prove valuable in the detailed assessment of such disorders in vivo. (Invest Ophthalmol Vis Sci. 2010;51:5254-5259) DOI:10.1167/iovs.09-5139

Harvard-Zitierstil: Fischer, M., Huber, G., Feng, Y., Tanimoto, N., Muehlfriedel, R., Beck, S., et al. (2010) In Vivo Assessment of Retinal Vascular Wall Dimensions, Investigative ophthalmology & visual science, 51(10), pp. 5254-5259. https://doi.org/10.1167/iovs.09-5139

APA-Zitierstil: Fischer, M., Huber, G., Feng, Y., Tanimoto, N., Muehlfriedel, R., Beck, S., Troeger, E., Kernstock, C., Preising, M., Lorenz, B., Hammes, H., & Seeliger, M. (2010). In Vivo Assessment of Retinal Vascular Wall Dimensions. Investigative ophthalmology & visual science. 51(10), 5254-5259. https://doi.org/10.1167/iovs.09-5139